Tristetraproline in breast cancer: treat or trick?
S. Kropyvko, A. Hubiernatorova, O. Mankovska, L. Syvak, N. Verovkina, S. Lyalkin, K. Lavrynenko, I. Ivasechko, R. Stoika, A. Rynditch
This study examines TTP expression and methylation changes in breast cancer subtypes and under chemotherapy, finding higher TTP in HER2-enriched tumors and differential methylation effects of temozolomide and doxorubicin.
bioRxiv · May 23, 2022Cancer Biology